Guardian Pharmacy (GRDN) earnings history
Most recent quarter
- Fiscal period
- Q2 2026
- Period end
- Jun 30, 2026
- EPS actual
- $0.29
- EPS estimate
- $0.26
- EPS surprise
- +10.81%
- Revenue surprise
- +3.32%
- Revenue
- $351.8M
- Revenue estimate
- $340.4M
- Reported
- Aug 6, 2026
Guardian Pharmacy reported Q2 2026 results on August 6, 2026. Earnings per share came in at $0.29, ahead of the $0.26 estimate by 10.81%. Revenue was $351.8 million, above the $340.4 million consensus. Compared with Q2 2025, EPS rose about 26% from $0.23 and revenue rose about 2% from $344.3 million.
The record is short. The table starts with Q3 2024, so it holds only eight quarters, and 2025 is the only full year. Guardian earned $1.00 per share in 2025 on revenue of $1.45 billion. Q4 2025 set the highs here at $0.37 per share and $397.6 million in revenue, and Q1 2025 was the EPS low at $0.15. In the first half of 2026, EPS totalled $0.58, about 53% more than a year earlier, on revenue about 2% higher. Revenue beat the estimate in all eight quarters. EPS beat it six times; the two misses were Q4 2024 and Q1 2025.
Guardian reported Q3 on November 12, 2024 and November 10, 2025. If that pattern holds, the next report would come around mid-November 2026. It will show whether EPS keeps running above the year-earlier level, after Q3 2025 came in at $0.25 per share.
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Aug 6, 2026 | $0.26 | $0.29 | +10.81% | $351.8M | SEC |
| Q1 2026 | May 6, 2026 | $0.24 | $0.29 | +20.83% | $336.6M | SEC |
| Q4 2025 | Mar 11, 2026 | $0.27 | $0.37 | +38.32% | $397.6M | SEC |
| Q3 2025 | Nov 10, 2025 | $0.24 | $0.25 | +6.38% | $377.4M | SEC |
| Q2 2025 | Aug 11, 2025 | $0.19 | $0.23 | +18.99% | $344.3M | SEC |
| Q1 2025 | May 12, 2025 | $0.22 | $0.15 | −31.82% | $329.3M | SEC |
| Q4 2024 | Mar 3, 2025 | $0.22 | $0.19 | −13.64% | $338.6M | SEC |
| Q3 2024 | Nov 12, 2024 | $0.19 | $0.28 | +43.15% | $314.4M | SEC |
Quarterly revenue
Frequently asked questions
When did Guardian Pharmacy (GRDN) last report earnings?
Guardian Pharmacy last reported on Aug 6, 2026, covering fiscal Q2 2026.
Did GRDN beat earnings estimates?
Yes. Guardian Pharmacy reported EPS of $0.29 for Q2 2026 against a $0.26 estimate — a 10.81% beat.
How much revenue did GRDN report last quarter?
Guardian Pharmacy reported $351.8M in revenue for Q2 2026, against a consensus estimate of $340.4M.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.